• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于连续输注凝血因子浓缩物的泵的综述:有哪些选择?

Review of pumps for continuous infusion of coagulation factor concentrates: what are the options?

作者信息

Martinowitz U, Schulman S

机构信息

Division of Hematology, National Hemophilia Center, Tel-Hashomer, Israel.

出版信息

Blood Coagul Fibrinolysis. 1996 Mar;7 Suppl 1:S27-33.

PMID:8735794
Abstract

Continuous infusion of coagulation factor concentrates has become more popular in recent years because it can substantially reduce the cost of surgery for a patient with hemophilia. This technique has also been used successfully for treatment of severe bleeds, induction of immune tolerance and short-term prophylaxis. The large selection of devices complicates the choice of an infusion system for this delivery approach. However, choosing the best type of device for a particular situation may determine the success or failure of continuous infusion.

摘要

近年来,凝血因子浓缩物的持续输注越来越普遍,因为它可以大幅降低血友病患者的手术成本。该技术也已成功用于治疗严重出血、诱导免疫耐受和短期预防。大量可供选择的设备使为这种给药方式选择输注系统变得复杂。然而,为特定情况选择最佳类型的设备可能决定持续输注的成败。

相似文献

1
Review of pumps for continuous infusion of coagulation factor concentrates: what are the options?用于连续输注凝血因子浓缩物的泵的综述:有哪些选择?
Blood Coagul Fibrinolysis. 1996 Mar;7 Suppl 1:S27-33.
2
Prophylaxis and continuous infusion for hemophilia: can we afford it?血友病的预防和持续输注:我们负担得起吗?
Blood Coagul Fibrinolysis. 1996 Mar;7 Suppl 1:S35-7.
3
Rationale and indications for continuous infusion of antihemophilic factor (factor VIII).
Blood Coagul Fibrinolysis. 1996 Mar;7 Suppl 1:S3-6.
4
Factor VIII pharmacokinetics: intermittent infusion versus continuous infusion.
Blood Coagul Fibrinolysis. 1996 Mar;7 Suppl 1:S11-4.
5
In vitro factor VIII recovery during the delivery of ultrapure factor VIII concentrate by continuous infusion.通过持续输注递送超纯凝血因子VIII浓缩物期间的体外凝血因子VIII回收率。
Am J Hematol. 1996 Feb;51(2):99-103. doi: 10.1002/(SICI)1096-8652(199602)51:2<99::AID-AJH1>3.0.CO;2-1.
6
Continuous infusion of coagulation factors: current opinion.凝血因子的持续输注:当前观点
Curr Opin Hematol. 2006 Sep;13(5):308-15. doi: 10.1097/01.moh.0000239701.32674.e0.
7
Inhibitor development in patients with hemophilia A after continuous infusion of FVIII concentrates.连续输注FVIII浓缩物后甲型血友病患者体内抑制剂的产生
Ann N Y Acad Sci. 2005 Jun;1051:498-505. doi: 10.1196/annals.1361.094.
8
Stability of ADVATE, Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method, during simulated continuous infusion.ADVATE(重组抗血友病因子,无血浆/白蛋白法)在模拟持续输注过程中的稳定性。
Blood Coagul Fibrinolysis. 2006 Apr;17(3):165-71. doi: 10.1097/01.mbc.0000220236.92219.08.
9
Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.持续输注重组凝血因子VIIa治疗VIII因子抑制物患者时,凝血因子VII活性与临床疗效的关系
Thromb Haemost. 2001 Oct;86(4):954-8.
10
[Recombinant factor VIIa (eptacog alfa): a new therapeutic option for patients with severe bleeding disorder due to inhibitory antibodies against a coagulation factor].
Ned Tijdschr Geneeskd. 1998 Jun 20;142(25):1464-7.